For Immediate Release

Chicago, IL – March 27, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Baker Hughes, Inc. (BHI), International Business Machines Corp. (IBM), China Mobile Ltd. ADS (CHL), Neurocrine Biosciences, Inc. (NBIX) and Potash Corp. (POT).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Thursday’s Analyst Blog:

Baker-Hughes a Buy Up to $50

Our continued favorable view of Baker Hughes, Inc. (BHI) shares reflects the company’s limited exposure to the weak North American natural gas market, its leading product-centric asset portfolio with a strong international presence, and excellent financial health.

While the operating environment remains challenging worldwide, the hardest hit region is the onshore U.S. market due to its natural gas-centric orientation. Of the large-cap service players, Baker Hughes has the least exposure to this market.

IBM to Cut as Many as 5,000 Jobs

An Employees Union source within International Business Machines Corp. (IBM) has announced that IBM will cut over 4,000 employees (possibly 5,000), mostly from the Global Business Services group, mainly in the US, starting today, Thursday, March 26. The work may be sourced to IBM’s facilities in India. The company had a total workforce of 398,455 as of the end of 2008, with about 115,000 in the US.

From a geographic perspective, the Americas’ 4th-quarter revenues were $11.5 billion, a decrease of 2.0% year-over-year (up 2.0%, adjusting for currency). Revenues from Europe/Middle East/Africa were $9.5 billion, down 12.0% (1.0%, adjusting for currency). Asia-Pacific revenues decreased 1.0% (1.0%, adjusting for currency) to $5.5 billion.

China Mobile Shows Strength

China Mobile Ltd. ADS (CHL), the largest wireless carrier in the world, continues to deliver healthy operating results as evidenced by strong subscriber accretion in 2008. The company exited the year with 72% share of the Chinese wireless market.

However, growth slowed in late 2008 due to general economic conditions and increased competition. Nevertheless, it remains our view that the new competitive entities will face unanticipated challenges deploying and advancing services to levels and coverage delivered by China Mobile.

NBIX Releases Positive Results

On March 25, 2009, Neurocrine Biosciences, Inc. (NBIX) reported results from the phase II -702 study, also called Lilac Petal, testing elagolix for the treatment of endometriosis.

Elagolix met the primary efficacy goal for both the 150mg and 250mg on the clinically validated PGI-C scale for both overall lower PGI-C score and percent of women with a score below 2. The 150mg dose was also statistically significant for the clinically validated EHP scale.

Potash a Hold at Current Price

Potash Corp. (POT), the world’s leading producer of potash and the largest fertilizer producer, has benefited from higher fertilizer application rates, higher crop plantings and increasing demand for biofuels. Rising fertilizer prices, especially potash, boosted Potash Corp’s earnings in 2008.

The company’s manufacturing plants are located in low-cost areas and its financials are solid. However, the global economic crisis and weakened demand are matters of concern. These force us to maintain our Hold rating of the stock.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks “Profit from the Pros” e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it’s your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

Zacks Investment Research

Last 5 posts by Zacks Market Commentaries

• Dress Barn Tops, Lifts Outlook - Analyst Blog - November 23rd, 2009
• Another Price Cut for Palm - Analyst Blog - November 23rd, 2009
• Ford Focuses on Brazil - Analyst Blog - November 23rd, 2009
• Ratings Action on Assurant - Analyst Blog - November 23rd, 2009
• Sands China Raises $2.5B in IPO - Analyst Blog - November 23rd, 2009